Keywords
chemoradiotherapy
prognosis
How to Cite
Abstract
Over the past decade, there are significant advances in the problem of studying the pathogenesis, clinical course and treatment of cervical disease. However, cervical cancer now continues to occupy one of the first places in the world among all malignant neoplasms of female genital mutilation. We study cases of CС with histologically confirmed cervical cancer with performing of different scheme of RT and CRT. Results of our research of combined and complex treatment in patients with locally advanced cervical cancer testify to the advantage of our proposed scheme of neoadjuvant CRT, which allows further radical surgical treatment and significantly improves results of 3 years disease-free survival.
References
Клиническая онкогинекология / [В. В. Кузнецов, В. П. Козаченко, А. И. Лебедев и др.] / под ред. В. П. Козаченко. – М., 2005. – 376 c.
Современные подходы к лечению рака шейким матки / К.Ю. Морхов, В.В. Кузнецов, А.И. Лебедев [и др.] // Эффективная фармакотерапия в онкологии, гематологии и радиологии. – 2005. – № 1. – С. 16–20.
Histopathologic prognostic factors in stage IIb cervical carcinoma treated with radical hysterectomy and pelvic-node dissection – an analysis with mathematical statistics / T. Kamura, N. Tsukamoto, N. Tsuruchi [et al.] // Int. J. Gynecol. Cancer. – 1993. – Vol. 3. – P. 219–225.
Reassessment of myo-metrial invasion / T. Kawagoe, N. Tsukamoto, N. Tsurushi [et al.] // Int. J. Gynecol. Cancer. – 1999. – Vol. 9. – P. 421–426.
Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy / N. Takeda, N. Sakuragi, M. Takeda [et al.] // Acta. Obstet. Gynecol. Scand. – 2002. – Vol. 81 (12). – P. 1144–1151.
Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in patients with Stages IB, IIA, and IIB cervical carcinoma treated with radical hysterectomy / N. Sakuragi, C. Satoh, N. Takeda [et al.] // Cancer. – 1999. – Vol. 85. – P. 1547–1554.
Impact on survival following successful neoadjuvant chemotherapy and radical surgery for Stage IIb bulky and Stage IIIb cervical cancer / T. Sugiyama, T. Nishida, Y. Hasuo Y. [et al.] // Gynecol. Oncol. – 1998. – Vol. 69 (2). – P. 130–136.
Умарова С. Г. Изучение процессов генерализации рака шейки матки после проведенного лечения с использованием математических методов исследования по ЭВМ : автореф. дис. на соискание ученой степени канд. мед. наук : спец. 14.00.14 «Онкология» / С. Г. Умарова. – Ташкент, 1992. –
с.
Туркевич В. Г. Лучевое лечение первичного и метастатического рака влагалища / В. Г. Туркевич // Практическая онкология. – 2006. – Т. 7, № 4 . – С. 236–245.
Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study / P. Benedetti-Panici, S. Greggy, A. Colombo [et al.] // J. Clin. Oncol. – 2002. – Vol. 20. – P. 179–188.
Prognostic factors in surgically treated stage ib-iib cervical carcinomas with special emphasis on the importance of tumor volume / M. Trattner, A.H. Graf, S. Lax [et al.] // Gynecol. Oncol. – 2001. – Vol. 82 (1). – P. 11–16.
Prognostic significance of preoperative DNA flow cytometry in surgically-treated cervical cancer / O. Reich, P. Pürstner, P. Klaritsch [et al.] // Gynecol. Oncol. – 2002. – Vol. 84. – P. 252–257.
UCSC experience on neoadjuvant chemotherapy (NACT) or radical surgery (RS) in locally advanced cervical cancer (LACC): Multivariate analysis of prognostic factors / P. Benedetti-Panici, S. Greggi, G. Scambia [et al.] // Gynecol. Oncol. – 1994. – Vol. 41. – P. 212.
Randomized trial of neoadjuvant chemotherapy (NACT) followed by radical surgery (RS) vs exclusive radiotherapy (RT) in locally advanced sguamous cell cervical cancer (LASCCC). An Italian multicenter study / P. Benedetti-Panici, F. Landoni, S. Greggi [et al.] // Int. J. Gynecol. Cancer. – 1997. – Vol. 7 (supple 2). – P. 18 (abstract).
Iwasaka T. Neoadjuvant chemotherapy with mitomycin C, etoposide, and cisplatin for adenocarcinoma of the cervix / T. Iwasaka, K. Fukuda, K. Hara // Gynecol Oncol. – 1998. – № 70 (2). – Р. 236–240.
Clinical response to «quick cisplatin and etoposide» as neoadjuvant chemotherapy and its outcome in the uterine cervical cancer patients of stage Ib2-IIIb / S.I. Kim, S.E. Namkoong, J.H. Kim [et al.] // Int. J. Gynecol. Cancer. – 1997. – Vol. – P. 39.
Rose P. Locally advanced cervical carcinoma: the role of chemoradiation / P. Rose // Semin. Oncol. – 1994. – Vol. 21 (1). – P. 47–53.
Neoadjuvant chemotherapy follow by radical hysterectomy and postoperative adjuvant chemotherapy in the treatment of carcinoma of the cervix uteri / C. Sananes, A. Giaroli, N. Guardado [et al.] // Europ. J. Gynecol. Oncol. – 1998. – № 4. – Р. 368–373.
Treatment of Sguamous cell carcinoma of head and neck with carboplatin and 5-FU / S. Saracchini, C. Gatti, C. A. Mione [et al.] // EJC. – 1991. – Vol. 27. – supple 2. – Р. 14.
Максимов С. Я. Химиолучевая терапия рака шейки и рака тела матки / С. Я. Максимов, К. Д. Гусейнов, С. Б. Баранов // Практическая онкология – 2008. – Т. 9, № 1 – С. 39–46.
What is the difference between squamous cell carcinoma and adenocarcinoma of the cervix? A matched case-control study / K. B. M. Lee, J. M. Lee, C. Y. Park [et al.] // Int. J. Gynecol. Cancer. – 2006. – Vol. 16. – P. 1569–1573.
An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: a Gynecologic Oncology Group Study / K. Y. Look, V. L. Brunetto, D. L. Clarke-Pearson [et al.] // Gynecol. Oncol. – 1996. – Vol. 63. – P. 304–311.
Contribution of pelvic and para-aortic lymphadenectomy with sentinel node biopsy in patients with IB2–IIB cervical cancer / E. Chéreau, J.-G. Feron, M. Ballester [et al.] // British Journal of Cancer. – 2012. – Vol. 106. – P. 39–44. – DOI: 10.1038/bjc.2011.541.
Residual pelvic lymph node involvement after concomitant chemoradiation for locally advanced cervical cancer / G. Houvenaeghel, L. Lelievre, A. L. Rigouard [et al.] // Gynecol. Oncol. – 2006. – Vol. 102 (1). – P. 74–79.
Костромина К. Н. Современная стратегия лучевого лечения больных раком шейки матки / К. Н. Костромина // Роль лучевой терапии в гинекологической онкологии: научно-практическая конференция: материалы конф. – Обнинск, 2002. – С. 107–111.
Лучевая терапия местнораспространенного рака шейки матки / О.А. Кравец, Л.А. Марьина, В.Н. Чехонадский, А.О. Русанов // Роль лучевой терапии в гинекологической онкологии: научно-практическая конференция: марериалы конф. – Обнинск, 2002. – С. 112–114.
Крикунова Л. И. Лучевая терапия рака шейки матки / Л. И. Крикунова // Практическая онкология. – 2002. – Т. 3, № 3. – С. 194–199.
Вишневская Е. Е. Рак шейки матки / Е. Е. Вишневская // Минск. – 1987. – С. 236.
Жаринов Г. М. Лучевая терапия больных раком шейки матки : автореф. дис. на соискание ученой степени д-ра мед. наук : спец 14.01.12 «Онкология» / Г. М. Жаринов. – СПб., 1993. – 20 с.
Габелов А. А. Зависимость результатов лучевого лечения больных раком шейки матки от объема опухоли / А. А. Габелов, Г. М. Жаринов // Мед. радиология. – 1981. – № 3. – С. 33–35.
Expression of hypoxic-inducible factor 1 alpha predicts metastasis-free survival after radiation therapy alone in stage IIIB cervical squamous cell carcinoma / H. Ishikawa, H. Sakurai, M. Hasegawa [et al.] // Int. J. Radiat. Oncol. Biol. Phys. – 2004. – Vol. 60 (2). – Р. 513–521.
Radiotherapy for uterine cervical cancer: results of the 1995–1997 patterns of care process survey in Japan / Т. Toita, K. Nakamura, T. Uno [et al.] // Jpn. J. Clin. Oncol. – 2005. – Vol. 35 (3). – Р. 139–148.
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer / M. Morris, P.J. Eifel, J. Lu [et al.] // N. Engl. J. Med. – 1999. – Vol. 340. – P. 1175–1178.
Kornovski Y. Neoadjuvant chemotherapy followed by radical surgery and radiotherapy vs. pelvic irradiation in patients with cervical cancer FIGO stage IIB–IVA / Y. Kornovski, G. Gorchev // J.BUON. – 2006. – Vol. 11 (3). – P. 291–297.
Морхов К. Ю. Комплексное лечение рака шейки матки Т2bNo-1Mo : дис. на соискание ученой степени канд. мед. наук : спец. 14.00.14 «Онкология» / К. Ю. Морхов. – М., 2002. – 157 с.